Calcitonin gene-related peptide (CGRP) inhibitors are a relatively new type of medication approved by the Food and Drug Administration (FDA) to treat and prevent migraines with or without aura. They ...
Pramlintide, exenatide, α-glucosidase inhibitors, and the glinides are not included in this algorithm, owing to their generally lower overall glucose-lowering effectiveness, limited clinical data ...
The specific diabetes medication can depend on a person’s plan. They may include alpha-glucosidase inhibitors, biguanides, glucagon-like peptide 1 (GLP-1) receptor agonists, meglitinides ...
metformin — 500mg, 850mg, 1000mg tabs Adults: ≥17yrs: Monotherapy: initially 500mg twice daily or 850mg once daily; may increase by increments of 500mg at 1wk intervals or 850mg in divided ...
ATX968 was identified as a potent and selective inhibitor of DHX9 helicase activity. Chemical inhibition of DHX9 enzymatic activity elicited similar selective effects on cell proliferation as seen ...
Janus kinase (JAK) inhibitors are a group of medications that can treat various types of arthritis, including rheumatoid arthritis (RA), cancer, dermatological conditions like atopic dermatitis and ...
School of Pharmacy, Health Science Center, Xi’an Jiaotong University, Xi’an, Shaanxi 710061, P. R. China ...
Revumenib is the first drug in a new class called menin inhibitors to receive FDA approval. The trial that brought about the drug’s approval was led by Eytan Stein, MD, Chief of the Leukemia Service ...
The State Key Laboratory of Chemical Oncogenomics, Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, P. R. China The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback